Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
10.14
-0.22 (-2.12%)
Jan 17, 2025, 4:00 PM EST - Market closed
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $780.33 million as of January 21, 2025. Its market cap has increased by 54.90% in one year.
Market Cap
780.33M
Enterprise Value
424.40M
1-Year Change
54.90%
Ranking
Category
Stock Price
$10.14
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.51M to $780.33M, an increase of 66.91%. That is a compound annual growth rate of 8.20%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |